This mechanism is particularly evident in hepatocellular carcinoma (HCC), where the synergistic interaction between ERK1/2 and Pl3K signaling enhances cell proliferation and survival in response to growth factors (Kim et al., 2019[62]). Here, MAPK3 is linked to hepatocellular carcinoma.